Continuing Education Courses
This continuing education (CE) course provides an understanding of biological products and biosimilar products and a description of FDA’s general approach to the development and approval of biosimilar products. The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, pharmacists., and pharmacy technicians.
The purpose of this continuing education (CE) course is to educate a national audience of health care providers, industry, and consumers about the basics of the FDA drug regulatory process and the science that supports CDER’s mission. The course will also educate the nation’s health care providers about their role in communicating drug information to their patients. This updated CDERLearn course replaces the former CDERLearn course, "The Past, Present, and Future of Human Drug Regulation."
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes
This continuing education (CE) course will educate a national audience of healthcare providers (physicians, pharmacists, nurses, and others) about the reduction of hypoglycemic events in Type 2 diabetes.